|Events|May 1, 2023
Compliance Congress for Specialty Products (9/19-9/21)
September 19-21, 2023 | Boston, MA
Reunite with Your Community to Overcome the Unique Risks & Challenges Associated with Complex Therapeutics
Bridge the gap between niche markets and industry standards to accelerate towards a solution catered exclusively for specialty pharmaceutical companies focuses on rare, ultra-rare and orphan diseases.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
2
Seamless Therapeutics Enters $1.12 Billion Global Research Collaboration with Eli Lilly to Develop Therapeutics for Hearing Loss
3
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
4
Pharmaceutical Executive Daily: Eli Lilly Enters $1 Billion Research Collaboration with Seamless Therapeutics
5